Trial completion date • Trial primary completion date • Post-transplantation
|
ALK (Anaplastic lymphoma kinase) • MYC (V-myc avian myelocytomatosis viral oncogene homolog) • BCL2 (B-cell CLL/lymphoma 2) • BCL6 (B-cell CLL/lymphoma 6)
|
ALK positive • ALK negative
|
Opdivo (nivolumab) • Yervoy (ipilimumab)